Pharma Equity Group (PEG) Investor Update summary

Commercial relationship strategy and leadership

• Pernille Lyngholm-Kjærby appointed as Commercial Relationship Director, bringing over 20 years of life science experience, scientific and business expertise, and leadership roles to drive partnership efforts.

• Holds a Master of Pharmaceutical Science and an MBA, with expertise in negotiation, market access, strategy, and leadership.

• The position was created to accelerate partnership outreach and deliver on revenue-related milestones.

• Focus is on expanding the professional network, especially among clinicians, key opinion leaders, academic institutions, and medical associations to enhance credibility and support clinical strategy.

• Efforts are underway to secure ambassadorship from influential clinicians in Denmark and internationally to strengthen market positioning.

Market analysis and partnership approach

• Comprehensive market and competitive analysis is being conducted, including product overview, competitor identification, target audience profiling, regulatory landscape, market trends, entry barriers, pricing, reimbursement, risk assessment, and revenue forecasting.

• Utilizes online resources, clinical trial databases, and direct stakeholder engagement for competitor and market analysis.

• Strategic fit, financial strength, commercialization experience, development capabilities, IP, reputation, and cultural compatibility are key criteria for selecting potential partners.

• Ideal partners share vision, complement strengths, communicate transparently, and focus on patient-centric outcomes.

• Ethical standards and high-quality standards are essential in partnership considerations.

Partnership pipeline and timeline

• A shortlist of top five major potential partners has been identified, with outreach prioritized for those offering speed and strategic alignment.

• Initial outreach to key opinion leaders in relevant therapeutic areas has begun, leveraging their networks to expand influence.

• The first partnership agreement, expected to include royalties, is targeted for 2025, aligning with anticipated revenue streams.

• License agreement structures are flexible, potentially including upfront payments, royalties, or milestone-based payments, depending on negotiations.

• Outreach strategy aims to identify and engage complementary companies for partnerships.